Jessica Reed is the Vice President of Development at Diapin Therapeutics. Diapin is developing best in class medicines for cardiovascular and metabolic diseases.

If you are interested in following up on this opportunity or learning more about ICAN, please contact me at [email protected]

*Disclaimer

The content presented in the “Why Should I Invest?” podcast is for informational and educational purposes only.ICAN does not solicit or offer securities. No part of this podcast constitutes an offer to sell, a solicitation of an offer to buy, or a recommendation for any security or investment. Listeners should conduct their own due diligence or consult with a licensed financial advisor before making investment decisions. ICAN is not a broker-dealer, investment advisor, or crowdfunding platform. Participation in any investment opportunity must comply with all applicable laws and regulations.